Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants greater than or equal to 36 weeks EGA~* Intrauterine opioid exposure~* Primary diagnosis of NAS~* Parental permission to participate~Exclusion Criteria:~* Infants less than 36 weeks EGA~* Major congenital anomalies~* Latrogenic drug withdrawal~* Diagnosis of infection or respiratory distress~* Prior initiation of opioid replacement therapy~* Non-English speaking~* Infants with respiratory conditions

- Gender: ALL
- Minimum Age: None
- Maximum Age: 2 Weeks
- Healthy Volunteers: f

Study Arms:
- Standard therapy plus Aromatherapy (Type: EXPERIMENTAL): These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.
- Standard therapy ALONE (Type: NO_INTERVENTION): These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).